Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generics Industry Must Play ‘Crucial Role’ In AMR Industry Alliance

Executive Summary

Generics firms have a crucial role to play in the fight against antimicrobial resistance, Thomas Cueni, chair of the AMR Industry Alliance, tells Generics Bulletin in an exclusive interview.

You may also be interested in...



Industry Needs To Engage On Antimicrobials

Recruiting generics firms to the AMR Industry Alliance is a key area of focus for the group as part of its efforts to cover a greater proportion of the global supply of antimicrobials, according to the Alliance’s latest report.

Industry must step up to tackle AMR threat

Generics manufacturers must “step up” to tackle antimicrobial resistance (AMR), the Access to Medicine Foundation has insisted, in a report that “systematically evaluates how a cross-section of the pharmaceutical industry is responding to the AMR threat”.

AMR report depicts industry commitment

Medicines for Europe is among the healthcare industry stakeholders who have welcomed the first report on antimicrobial resistance (AMR) by the AMR Industry Alliance, which “brings together over 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations from 20 countries” and shows that “broadly the Alliance membership is already active and making positive contributions to the challenge of AMR”.

Topics

UsernamePublicRestriction

Register

SC142496

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel